10.5 Post-Transcriptional Processing of Eukaryotic Pre-mRNA

10.5 Post-Transcriptional Processing of Eukaryotic Pre-mRNA

3. Post-Transcriptional Processing of Eukaryotic Pre-mRNA

In prokaryotes, which lack a nuclear envelope, ribosomes begin translating nascent mRNA molecules while RNA polymerase is still transcribing them (coupled transcription-translation). In eukaryotes, spatial compartmentalization requires the primary transcript (heterogeneous nuclear RNA, or hnRNA) to undergo three co- and post-transcriptional modifications inside the nucleus to yield export-competent mature mRNA:

1. The 5' 7-Methylguanosine (m7G) Cap

• Mechanism: Added co-transcriptionally when the nascent transcript reaches 20–30 nucleotides in length. Capping enzymes docked on the phosphorylated CTD of RNA Pol II execute three enzymatic steps:
  1. RNA triphosphatase removes the terminal γ-phosphate from the 5' nucleotide.
  2. Guanylyltransferase condenses GTP with the diphosphate 5' end, forming an atypical 5'-to-5' triphosphate linkage (5'-ppp-5').
  3. Guanine-7-methyltransferase transfers a methyl group from S-adenosylmethionine (SAM) to the N7 position of the terminal guanine.
• Biological Significance:
  • Protects mRNA from rapid degradation by cytoplasmic 5' → 3' exoribonucleases (e.g., XRN1).
  • Acts as a specific binding platform for the nuclear cap-binding complex (CBC) to mediate nuclear export through nuclear pore complexes.
  • Serves as the primary docking recognition motif for eIF4E (part of the eIF4F complex) during ribosomal translation initiation in the cytoplasm.

2. 3' Polyadenylation

• Mechanism: Transcription continues past the end of the gene until RNA Pol II transcribes a conserved polyadenylation signal: 5'-AAUAAA-3', followed 10–30 nucleotides downstream by a GU-rich downstream element.
  1. The Cleavage and Polyadenylation Specificity Factor (CPSF) and cleavage stimulation factor (CstF) bind these consensus sequences.
  2. An endonuclease cleaves the nascent pre-mRNA 10–30 nucleotides downstream of the AAUAAA motif.
  3. Poly(A) Polymerase (PAP) sequentially adds approximately 200–250 adenine residues to the newly generated free 3'-hydroxyl terminus. Crucially, PAP catalyzes this template-independent reaction using cellular ATP (ATP → poly(A) + PPi).
• Biological Significance:
  • Protects the 3' terminus from 3' → 5' exoribonucleolytic degradation.
  • Bound by Poly(A)-Binding Proteins (PABP), which interact with eukaryotic initiation factor 4G (eIF4G) at the 5' cap to circularize mRNA, enhancing translational efficiency and ribosomal recycling.
  • Deadenylation (shortening of the poly-A tail) serves as a primary molecular timer initiating mRNA degradation.

3. Pre-mRNA Splicing and the Spliceosome

Eukaryotic structural genes are non-continuous mosaic sequences: expressed coding sequences (exons) are interrupted by non-coding intervening sequences (introns) that must be excised with nucleotide-level precision.

Consensus Splice Sequences in Pre-mRNA:
5' Exon --[5' Donor: GU]----------------(Branch Point A)----[Py-rich tract]----[3' Acceptor: AG]-- Exon 3'

• Consensus Sequence Motifs:
  • 5' Splice Donor Site: Invariant GU dinucleotide at the 5' end of the intron.
  • 3' Splice Acceptor Site: Invariant AG dinucleotide at the 3' end of the intron.
  • Branch-Point Adenosine: An invariant adenine residue located 20–50 nucleotides upstream of the 3' splice site.
  • Polypyrimidine Tract: A tract of pyrimidines (C and U) immediately preceding the 3' acceptor site.
• The Two Transesterification Reactions:
  1. First Transesterification: The nucleophilic 2'-hydroxyl group of the internal branch-point adenosine attacks the phosphodiester bond at the 5' splice donor site (GU). This cleaves the 5' exon-intron boundary and forms an atypical 2'-to-5' phosphodiester bond between the branch-point adenosine and the 5' terminal guanine of the intron, creating a branched lariat intermediate.
  2. Second Transesterification: The liberated, free 3'-hydroxyl group of the upstream exon attacks the phosphodiester bond at the 3' splice acceptor site (AG). This ligates the two exons via a standard 3'-to-5' phosphodiester bond and releases the excised intron as a lariat, which is subsequently debranched and degraded.

Spliceosome Machinery: Catalyzed by the spliceosome, a 60S ribonucleoprotein megadalton machine composed of five small nuclear ribonucleoproteins (snRNPs: U1, U2, U4, U5, U6) complexed with >100 auxiliary proteins. U1 snRNA base-pairs with the 5' splice site, U2 snRNA base-pairs with the branch point (bulging out the branch-point adenosine), and U4/U6/U5 form the catalytic core where U6 and U2 snRNAs act as ribozymes.

Alternative Splicing: Generating Proteomic Diversity

In humans, approximately 95% of multi-exon genes undergo alternative splicing, wherein pre-mRNAs can be spliced in multiple permutations by selecting alternative 5' or 3' splice sites, skipping exons, or retaining introns. Alternative splicing enables a single genomic gene to encode multiple distinct protein isoforms exhibiting tissue-specific, developmental, or physiological differences:

• Calcitonin vs. CGRP: In thyroid C-cells, alternative splicing of the CALCA gene transcript yields calcitonin (involved in calcium homeostasis), whereas alternative splicing of the exact same primary transcript in neural tissue yields calcitonin gene-related peptide (CGRP), a potent vasodilatory neuropeptide.
• Immunoglobulin Membrane vs. Secretory Isoforms: B-cell maturation alters alternative splicing of the heavy-chain transcript to remove hydrophobic transmembrane anchoring exons, switching IgM from a membrane-bound B-cell receptor to a soluble, secreted antibody.